Offering levodopa/carbidopa as a 24-hour continuous subcutaneous infusion could help to improve treatment on times and motor experiences of daily living compared with oral preparations.
Medscape Medical News
LD/CD Infusion Improves "ON" Time, Outcomes in Parkinson’s
